K

Keystone Clinical Studies, LLC | Norristown, PA

Research site

(Unclaimed)

Location

2460 General Armistead Avenue Suite 300, Norristown, Pennsylvania, United States of America

Site insights

Top conditions

Top treatments

Dasotraline

Rapastinel

Lecanemab

Bitopertin

Troriluzole

RO4917838

AVP-786

PF-05212377

Lurasidone HCl

Serotonin

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 15 total trials

A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease (Clarity AD)

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiorit...

Active, not recruiting

Early Alzheimer's Disease

Drug: Placebo

Drug: Lecanemab

AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid

The primary purpose of this study is to determine whether treatment with lecanemab is superior to placebo on change from baseline of the Preclinical...

Enrolling

Preclinical Alzheimer's Disease

Early Preclinical Alzheimer's Disease

Drug: Lecanemab

Drug: Placebo

Open Label Study of ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease

The objective of this study is to determine the safety and tolerability of fosgonimeton (ATH-1017) in subjects with mild to moderate Alzheimer's dise...

Active, not recruiting

Alzheimer Disease

Drug: ATH-1017